It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The organization got one step closer in getting the application ready to be used in human trials thanks to results of two studies published in the Dec. 2010 issue of the American Association of Cancer Research’s (Philadelphia) Clinical Cancer Research journal. The studies conducted by Steven Curley MD, and Evan Glazer show that RF fi elds can treat pancreatic tumors, which today, kill more than 95% of diagnosed patients. Studies found that noninvasive RF fi elds were effective in controlling relatively large malignant pancreatic tumors. Additionally, this process took place without any injury to surrounding tissue or changes in non-human subject behavior. “The ultimate goal for us, is to be able to get this device ready for human trials,” Neidig said. “And right now we’re about two and a half years away from doing that.” In both studies non-human subjects were exposed to 10 minutes of (RF) radiation followed by 36 hours of treatment using targeted gold nanoparticles (AuNP). This design shows that the Kanzius RF machine alongside these particular nanoparticles create an effective formula for controlling pancreatic cancer cells.
then 2.1 million looks a little paltry. Don't ya think?
Originally posted by Hundroid
An article on Medical Device Daily says the following:
The organization got one step closer in getting the application ready to be used in human trials thanks to results of two studies published in the Dec. 2010 issue of the American Association of Cancer Research’s (Philadelphia) Clinical Cancer Research journal. The studies conducted by Steven Curley MD, and Evan Glazer show that RF fi elds can treat pancreatic tumors, which today, kill more than 95% of diagnosed patients. Studies found that noninvasive RF fi elds were effective in controlling relatively large malignant pancreatic tumors. Additionally, this process took place without any injury to surrounding tissue or changes in non-human subject behavior. “The ultimate goal for us, is to be able to get this device ready for human trials,” Neidig said. “And right now we’re about two and a half years away from doing that.” In both studies non-human subjects were exposed to 10 minutes of (RF) radiation followed by 36 hours of treatment using targeted gold nanoparticles (AuNP). This design shows that the Kanzius RF machine alongside these particular nanoparticles create an effective formula for controlling pancreatic cancer cells.
So it seems we are getting close for human trials, finally. I really do not understand why it is so difficult to get authorizations for human trials while patients must suffer pain distress and physical damage because of chemio/radio treatments. Shame on you, big pharma.
Medical Device Dailyedit on 1-4-2011 by Hundroid because: Forgot the link
Originally posted by Miraj
reply to post by Hundroid
Very interesting..
I'll be reviewing their published research when I have time. This seems like a practical method to destroying cancer cells.
To other posters: The reason this will take awhile is because they have to be sure that the antibodies attached to the to the nano particles won't target any other cells. As they are many thousands of different types of cells (and millions, billions of cells togthether) they need to assure these gold nanoparticles do not bind into the heart.
Remember that just because of the fact that they seem sure in their method doesn't mean their method is sure. It's not a conspiracy necessarily, the government just does not move fast. If they can show effective results in trials, then it should probably be available for treatment within a couple of years..
Can you imagine the effect of something like that? The heart would be destroyed almost instantly, or surely. That's why it will take some time for human trials.